arrow
E

Elena Anghileri

Fondazione IRCCS Istituto Neurologico Carlo Besta
H指数:25
被引数:2,585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping integrated care for brain tumour–related epilepsy in the Italian RIN–IRCCS network

意大利RIN–IRCCS网络中脑瘤相关癫痫综合护理的映射

2026-06-260
OAAI
Decoding polymorphous low-grade neuroepithelial tumor of the young (PLNTY): Electroclinical features and molecular signatures in epilepsy surgery candidates

青年多形性低级别神经上皮肿瘤(PLNTY)的解读:癫痫手术候选者的电临床特征与分子标志物

2026-06-020
PRE
Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases

胶质母细胞瘤长期生存者的独特遗传和表观遗传改变:来自两个临床病例的见解

2025-10-140
OAAI
MEDIAN AND 2 YEARS SURVIVAL OF NEWLY DIAGNOSED UNMETHYLATED MGMT GLIOBLASTOMA PATIENTS TREATED WITH TEMFERON IMMUNO-GENE THERAPY
2024-11-110
PRE
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1

更新的EANO指南,用于选择靶向治疗的成人神经胶质瘤、神经胶质瘤和神经元肿瘤的合理分子检测-更新1

2024-10-101
OA
A macrophages-based immunotherapy of solid tumors microenvironment: Preliminary results of the TEM-GBM_01 study
2024-04-050
PRE
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study
2024-04-010
PRE
Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients
2022-12-269
OAAI
Targeting the tumor microenvironment of glioblastoma multiforme using a macrophage-based treatment for the local delivery of immune-therapeutic payload: The TEM-GBM study (NCT03866109)
2022-09-012
OA